Skip to main content
. 2006 Oct 5;6:237. doi: 10.1186/1471-2407-6-237

Figure 2.

Figure 2

Overall, event-free survival and relapse-free survival analyses of OS patients correlated with gene expression profiling of either biopsy or primary tumor resection onset groups. A- Overall, event-free survival and relapse-free survival of biopsy onset group with over-expression of THBS3, and relapse-free survival of primary tumor resection onset group with over-expression of THBS3. B- Overall, event-free survival and relapse-free survival of biopsy onset group with over-expression of SPARC.C- Overall, event-free survival and relapse-free survival of biopsy onset group with over-expression of the SPP1 gene.